Omar Abreu-Pino
Family · Hialeah, FLNPI 1891190526
Payments from drug & device makers
Across 64 payments — averaging $23.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$200
- Corcept Therapeutics$157
- Tandem Diabetes Care, Inc.$148
- AstraZeneca$134
- Boehringer Ingelheim$116
- Novo Nordisk$103
- plus $665 from 18 others
Across 9 payments — averaging $215.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi Pasteur Inc.$2K
What the payments were for
- Food & beverage$1,524100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 4 | $200 |
| Corcept Therapeutics | 9 | $157 |
| Tandem Diabetes Care, Inc. | 4 | $148 |
| AstraZeneca | 6 | $134 |
| Boehringer Ingelheim | 5 | $116 |
| Novo Nordisk | 5 | $103 |
| Lilly USA, LLC | 5 | $88 |
| Medtronic | 2 | $88 |
| Madrigal Pharmaceuticals | 3 | $66 |
| Exact Sciences | 3 | $63 |
| GSK | 3 | $56 |
| Sequel Med Tech, LLC | 2 | $47 |
| Xeris Pharmaceuticals, Inc. | 2 | $41 |
| Kyowa Kirin, Inc. | 1 | $27 |
| Insulet Corporation | 1 | $25 |
| Bayer | 1 | $25 |
| Dexcom, Inc. | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Amneal Pharmaceuticals LLC | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Ascendis Pharma Endocrinology Inc | 1 | $16 |
| AbbVie | 1 | $16 |
| Novartis | 1 | $16 |
| Saluda Medical Americas, Inc. | 1 | $15 |
How this compares
$1,524 in reported general payments places this provider in the 75th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 105 | $143,342 |
| JanuviaSitagliptin Phosphate | 72 | $87,922 |
| FarxigaDapagliflozin Propanediol | 58 | $70,380 |
| EntrestoSacubitril/Valsartan | 44 | $56,678 |
| XareltoRivaroxaban | 44 | $49,594 |
| JardianceEmpagliflozin | 37 | $46,326 |
| JanumetSitagliptin Phos/Metformin Hcl | 15 | $26,023 |
| OzempicSemaglutide | 26 | $25,216 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 36 | $25,153 |
| TradjentaLinagliptin | 21 | $24,682 |
| VascepaIcosapent Ethyl | 39 | $22,299 |
| TrulicityDulaglutide | 22 | $21,334 |
| SymbicortBudesonide/Formoterol Fumarate | 53 | $18,510 |
| Alcohol Prep PadsAlcohol Antiseptic Pads | 203 | $18,493 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 107 | $15,640 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Symbicort, Breztri Aerosphere | $134 | $98,531122 claims |
| Boehringer IngelheimJardiance, Tradjenta, Trijardy Xr | $116 | $85,91070 claims |
| NovartisEntresto | $16 | $56,67844 claims |
| Novo NordiskOzempic | $103 | $25,21626 claims |
| GSKTrelegy Ellipta | $56 | $25,15336 claims |
| Lilly USA, LLCTrulicity | $88 | $21,33422 claims |
| AbbVieLumigan, Combigan | $16 | $13,29855 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 14,618 family providers in Florida.
Other family in Hialeah
- David RodriguezHialeah$658K
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.